ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 657 filers reported holding ISHARES TR in Q2 2019. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $677,751 | -0.8% | 4,939 | -1.8% | 0.11% | +156.8% |
Q4 2023 | $683,329 | -45.0% | 5,030 | -50.5% | 0.04% | -42.1% |
Q3 2023 | $1,241,724 | +65.4% | 10,154 | +71.8% | 0.08% | +20.6% |
Q2 2023 | $750,630 | -1.6% | 5,912 | +0.1% | 0.06% | -6.0% |
Q1 2023 | $762,599 | -0.9% | 5,904 | +0.7% | 0.07% | -10.7% |
Q4 2022 | $769,479 | +13.2% | 5,861 | +0.8% | 0.08% | +2.7% |
Q3 2022 | $680,000 | +1.6% | 5,816 | +2.2% | 0.07% | +32.7% |
Q2 2022 | $669,000 | -2.0% | 5,690 | +8.5% | 0.06% | -26.7% |
Q1 2022 | $683,000 | -14.6% | 5,245 | 0.0% | 0.08% | -11.8% |
Q4 2021 | $800,000 | -5.7% | 5,245 | 0.0% | 0.08% | -19.0% |
Q3 2021 | $848,000 | -1.2% | 5,245 | 0.0% | 0.10% | -3.7% |
Q2 2021 | $858,000 | +12.2% | 5,245 | +3.3% | 0.11% | -1.8% |
Q1 2021 | $765,000 | -1.5% | 5,079 | -1.1% | 0.11% | -9.8% |
Q4 2020 | $777,000 | +124.6% | 5,134 | +1519.6% | 0.12% | +778.6% |
Q2 2019 | $346,000 | – | 317 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |